| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |